ARCA biopharma, Inc.
10170 Church Ranch Way, Suite 100
Westminster, Colorado 80021
(720) 940-2200
March 26, 2021
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Ms. Westbrook
Re: ARCA biopharma, Inc.
Registration Statement on Form S-3
File No. 333-254585
Acceleration Request | ||||
Requested Date: | Tuesday, March 30, 2021 | |||
Requested Time: | 4:00 p.m. Eastern Time |
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, ARCA biopharma, Inc. hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form S-3 to become effective at 4:00 p.m. Eastern Time on Tuesday, March 30, 2021, or as soon thereafter as is practicable.
If you have any questions regarding this request, please contact Brent D. Fassett of Cooley LLP at (720) 566 4025 or Ryan Lewis of CooleyLLP at (720) 576-1913.
Sincerely, | ||
ARCABIOPHARMA, INC. | ||
By: | /s/ Brian Selby | |
Brian Selby | ||
Vice President, Finance |